Anna Cappelletti

807 total citations
15 papers, 492 citations indexed

About

Anna Cappelletti is a scholar working on Infectious Diseases, Epidemiology and Hematology. According to data from OpenAlex, Anna Cappelletti has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in Anna Cappelletti's work include SARS-CoV-2 and COVID-19 Research (3 papers), Platelet Disorders and Treatments (3 papers) and SARS-CoV-2 detection and testing (3 papers). Anna Cappelletti is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Platelet Disorders and Treatments (3 papers) and SARS-CoV-2 detection and testing (3 papers). Anna Cappelletti collaborates with scholars based in Italy, Netherlands and Sweden. Anna Cappelletti's co-authors include Alberto Tosetto, Stefan Lethagen, Jeroen Eikenboom, Francesco Rodeghiero, Giancarlo Castaman, F. Baudo, Silvia Linari, Alok Srivastava, Javier Batlle and A B Federici and has published in prestigious journals such as Clinical Infectious Diseases, Clinical Chemistry and AIDS.

In The Last Decade

Anna Cappelletti

14 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Cappelletti Italy 9 296 89 80 70 60 15 492
Marisol Betensky United States 11 214 0.7× 64 0.7× 142 1.8× 33 0.5× 87 1.4× 49 434
Ulrik Sprogøe Denmark 13 251 0.8× 23 0.3× 49 0.6× 60 0.9× 159 2.6× 35 559
John Doyle Canada 14 352 1.2× 30 0.3× 34 0.4× 81 1.2× 80 1.3× 27 698
Tapio Nousiainen Finland 17 203 0.7× 70 0.8× 19 0.2× 67 1.0× 26 0.4× 32 647
Tina S. Ipe United States 12 92 0.3× 28 0.3× 69 0.9× 37 0.5× 31 0.5× 32 393
E Verdy France 9 187 0.6× 102 1.1× 77 1.0× 19 0.3× 38 0.6× 26 374
Peter B. Neame Canada 10 288 1.0× 22 0.2× 70 0.9× 67 1.0× 40 0.7× 19 541
Assaf Arie Barg Israel 12 346 1.2× 29 0.3× 32 0.4× 105 1.5× 58 1.0× 52 477
Malak Elbatarny Canada 9 188 0.6× 164 1.8× 111 1.4× 38 0.5× 29 0.5× 32 449
Pier Mannuccio Mannucci Italy 7 307 1.0× 68 0.8× 70 0.9× 54 0.8× 90 1.5× 8 467

Countries citing papers authored by Anna Cappelletti

Since Specialization
Citations

This map shows the geographic impact of Anna Cappelletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Cappelletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Cappelletti more than expected).

Fields of papers citing papers by Anna Cappelletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Cappelletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Cappelletti. The network helps show where Anna Cappelletti may publish in the future.

Co-authorship network of co-authors of Anna Cappelletti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Cappelletti. A scholar is included among the top collaborators of Anna Cappelletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Cappelletti. Anna Cappelletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Soria, Ana, Francesca Sabbatini, Anna Cappelletti, et al.. (2025). Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy. AIDS. 39(10). 1344–1352.
2.
Carta, Mariarosa, Michela Pascarella, Anna Cappelletti, Mario Rassu, & Davide Giavarina. (2022). Evaluating the role of a fully automated SARS-CoV-2 antigen ECLIA immunoassay in the management of the SARS COV 2 pandemic on general population. Diagnosis. 9(4). 491–498. 1 indexed citations
3.
Carta, Mariarosa, et al.. (2021). Comparison of Anti–SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine. American Journal of Clinical Pathology. 157(2). 212–218. 8 indexed citations
4.
Carta, Mariarosa, Andrea Tramarin, Anna Cappelletti, et al.. (2020). Anti SARS-CoV-2 antibodies monitoring in a group of residents in a long term care facility during COVID-19 pandemic peak. Diagnosis. 7(4). 395–400. 5 indexed citations
5.
Giavarina, Davide, Anna Cappelletti, & Mariarosa Carta. (2019). Improved workflow in routine-stat integration. Clinica Chimica Acta. 493. S52–S53. 2 indexed citations
6.
Mazzotta, Elena, Raffaella Rosso, Antonio Di Biagio, et al.. (2011). Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: a multicentric case–control study. Journal of Bone and Mineral Metabolism. 29(3). 383–388. 20 indexed citations
7.
Castaman, Giancarlo, Alberto Tosetto, Anna Cappelletti, et al.. (2010). Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD. Thrombosis Research. 126(3). 227–231. 22 indexed citations
8.
Walwema, Richard, Anna Cappelletti, Stefano Buttò, et al.. (2008). Subtype Assignment and Phylogenetic Analysis of HIV Type 1 Strains in Patients from Swaziland. AIDS Research and Human Retroviruses. 24(2). 323–325. 8 indexed citations
9.
Castaman, Giancarlo, Francesco Rodeghiero, Alberto Tosetto, et al.. (2006). Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. Journal of Thrombosis and Haemostasis. 4(10). 2164–2169. 46 indexed citations
10.
Rodeghiero, Francesco, Giancarlo Castaman, Alberto Tosetto, et al.. (2005). The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. Journal of Thrombosis and Haemostasis. 3(12). 2619–2626. 237 indexed citations
11.
Bongiovanni, Marco, Anna Cappelletti, Antonella d’Arminio Monforte, & Teresa Bini. (2005). Cutaneous B-cells non-Hodgkin's lymphoma in a HIV-infected female. Scandinavian Journal of Infectious Diseases. 37(1). 78–80. 2 indexed citations
12.
Milazzo, Laura, Manuela Piazza, O. Sangaletti, et al.. (2004). [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. Journal of Antimicrobial Chemotherapy. 55(1). 84–89. 32 indexed citations
13.
Galli, Massimo, Anna Lisa Ridolfo, Fulvio Adorni, et al.. (2003). Correlates of Risk of Adipose Tissue Alterations and Their Modifications over Time in HIV-1-Infected Women Treated with Antiretroviral Therapy. Antiviral Therapy. 8(4). 347–354. 12 indexed citations
14.
Gervasoni, Cristina, Anna Lisa Ridolfo, Mauro Vaccarezza, et al.. (2002). Thrombotic Microangiopathy in Patients with Acquired Immunodeficiency Syndrome Before and During the Era of Introduction of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 35(12). 1534–1540. 55 indexed citations
15.
Altinier, Sara, Monica Mion, Anna Cappelletti, Martina Zaninotto, & Mario Plebani. (2000). Rapid Measurement of Cardiac Markers on Stratus CS. Clinical Chemistry. 46(7). 991–993. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026